Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
XORTX Therapeutics Inc. (XRTX) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.81M |
|
-- |
|
-- |
|
$0.82M |
|
$-0.82M |
|
$0.01M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.82M |
|
$-0.80M |
|
1.39M |
|
1.39M |
|
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$0.74M |
|
$0.01M |
|
$1.40M |
|
$2.14M |
|
$0.86M |
|
-- |
|
-- |
|
$0.86M |
|
$1.28M |
|
$1.10M |
|
$1.28M |
|
1.39M |
|
| Cash Flow Statement Financials | |
$-0.50M |
|
$-0.01M |
|
$-0.10M |
|
$0.86M |
|
$0.25M |
|
$-0.61M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.86 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-62.97% |
|
-73.62% |
|
-37.69% |
|
-62.97% |
|
$0.92 |
|
$-0.36 |
|
$-0.36 |
|